Now that mental health is being given as much attention as physical health, it is becoming clearer as to how many people suffer from a mental illness. Depression is one common illness that is plaguing the United States. The leading cause of suicide, depression is becoming more prevalent in teens and young adults than it has ever before.
Although depression is one of the most serious mental disorders, it is also the most easily treated, usually with antidepressants. However, there is a new kid on the block in the form of more natural treatment, CBD (cannabidiol).
Let’s look at how CBD and depression work together and how CBD could be the future of treating mental health disorders:
CBD as a natural treatment for depression
CBD is a natural compound that is extracted from the hemp or cannabis plant. Now that hemp-derived CBD products containing 0.3% THC and less, research has picked up to discover just how powerful this plant really can be. Initial studies are pointing to CBD as an effective treatment for depression, anxiety and a range of other medical conditions.
Using CBD oil as a health supplement daily for its health-promoting properties could be beneficial to anyone and not just those suffering from mental illness. For depression, CBD as a natural compound can be highly effective in stabilizing serotonin levels without upsetting the body’s ecosystem with chemicals.
CBD tinctures or CBD soft gel capsules are great options to start with as well as CBD vaping to orally get CBD directly into the bloodstream for fast-acting benefits.
A safe alternative to antidepressants
CBD will not give you the high that you expect from smoking cannabis. This is because of the compound THC (tetrahydrocannabidiol), the psychoactive component that creates the mind-altering state that you get from smoking marijuana. Besides, it is safe to consume with no real risk of overdosing.
Traditional treatment for depression in the form of antidepressants can have a range of negative side effects on patients. These include things like insomnia, nausea, diarrhea, reduced blood clotting and loss of sex drive.
CBD also does not pose any risk of addiction since it has no addictive properties. This means that long term use of CBD will be favored over long term use of chemical-based antidepressants.
How does CBD treat depression?
The interaction of CBD and depression is still a little tricky to understand since research is lacking. However, with current research, we are able to understand the basic idea of how CBD can be used to help depressed patients.
When CBD enters the body’s bloodstream, it interacts with what is known as the endocannabinoid system. Believe it or not, but the human body produces its own cannabinoids. CBD, therefore, acts as a supplement to the body’s natural cannabinoids, improving the effect they have on the body.
When CBD comes into contact with receptors CB1 and CB2 in the body, it reduces the absorption of the neurotransmitter, anandamide. Known as the “bliss molecule,” anandamide is a potent (and natural) antidepressant produced by the body. Anandamide exhibits similar effects to endorphins, serotonin and dopamine, meaning the CBD can essentially help to improve mood and ultimately depression and anxiety.
Finding a high-quality CBD for depression
When it comes to CBD and depression, it is important to find a pure product to ensure the best results. Greenleaf Farms is an online store that provides various CBD products from CBD oil to CBD cream. All of their products are produced from organically grown hemp that is free from any harmful pesticides and herbicides.
The processes they use to cultivate hemp plants and extract the CBD means their CBD is of the highest and purest quality. With a THC concentration of 0.3% and less, these products are legal in all states across the US. Using a pure CBD product will ensure that your body responds correctly to the product to treat depression and anxiety. You will also not have any adverse reactions to pure CBD.
CBD and Diabetes Treatment
CBD and Diabetes Treatment
The hemp oil extracted from the cannabis plant is currently receiving good press for its ability to help in the treatment of certain conditions. The legalization of marijuana has made the use of cannabis products more socially acceptable.
CBD is different from marijuana. Marijuana products contain THC (tetrahydrocannabinol), the mood-altering compound. It causes the high most people to think about when cannabis is mentioned.
CBD (cannabidiol) contains less than 0.3% THC, so it won’t make you feel high. CBD has been found to have several healing properties that apply to a wide range of conditions.
CBD oil can be used in different forms. One of the ways many people to ingest it is using CBD soft gel capsules. Most producers, like Greenleaf Farms, make different cannabis products to suit the user.
CBD and diabetes – blood sugar levels
People with diabetes experience fluctuating blood sugar levels that need to be regulated by the use of insulin. Blood sugar levels rise when the body cannot adequately metabolize glucose. Glucose is present in sugary and starchy foods. People with diabetics must avoid such foods to prevent dangerous spikes in blood sugar levels.
Like introducing anything else to the diet, people with diabetes should exercise caution if they start using CBD. It is always wise to seek medical advice before doing so. A healthcare professional can discuss the pros and cons with a patient and form an opinion as to whether it is safe for them or not.
One of the chief concerns there may be with a person with diabetes using CBD is that research indicates that the body’s endocannabinoid system doesn’t inhibit insulin sensitivity. The system is fed by the endocannabinoids that the body produces naturally. External sources of cannabinoids like CBD will increase levels in the body.
Higher cannabinoid levels might affect the body’s sensitivity to insulin, which is what the body depends on to regulate blood sugar. Studies on the effect of CBD products on the endocannabinoid system are still ongoing. Many experts regard these studies as being in their infancy.
Where things stand now
At this stage, most of the evidence of the effectiveness of CBD and diabetes is anecdotal. Some users have reported a drastic drop in blood sugar levels immediately after using it. This can be dangerous for a person with diabetes. Others have reported no changes in their blood sugar levels. However, some state that their blood sugar levels have improved as a result of using CBD.
Are there ways that CBD can benefit people with diabetes?
Exercise is a vital component of diabetes management. Many people with diabetes complain about joint pain, which prevents them from exercising. Using CBD oil on the affected joints can help to ease the pain. CBD should be applied diluted with a carrier oil such as olive oil. Its anti-inflammatory properties can relieve the swelling in the joints.
People with diabetes are prone to slow-healing wounds, especially on their extremities, where blood circulation might be poor. CBD cream is useful for wounds as it is an anti-inflammatory. It is also an analgesic, which eases the pain. As an antioxidant, CBD helps to strengthen the immune system so that it can prevent wound infection.
A lot of people with diabetes report difficulty with maintaining a healthy sleep pattern. Some struggle to sleep, and others struggle to waken after sleep. A lot of people report that CBD oil helps to improve the quality of their sleep.
Advice for people with diabetes
- If you choose to buy CBD products, make sure you buy them from a reputable producer. A lot of less-reputable producers don’t disclose the full ingredient list for their products.
- Consult your doctor before trying CBD products. Do not change your treatment plan on your own. Diabetes has the potential to be debilitating or life-threatening.
- It might be preferable to use CBD topical products. More research is needed to determine if the ingestion of CBD will affect your blood sugar levels.
How Recent Results from Aurora Cannabis Inc (OTCMKTS:ACBFF) Suggest Bigger Things to Come
Aurora Cannabis Inc (OTCMKTS:ACBFF) continues to be a clear market leader in terms of raw access to growth in the Canadian cannabis sector as we approach the full adult-use legalization date later this month. This was again on display last week as the company hit the tape with its latest quarterly report.
“Aurora made substantial progress toward our strategic goal of becoming the global scale and margin leader in the cannabis industry, establishing a vertically integrated company with a broadly diversified product offering with a large global footprint,” said Terry Booth, CEO of Aurora. “Our high-pace, consistent execution has enabled us to complete a number of transformative acquisitions, bringing together industry-leading companies in terms of scale, quality, efficiencies, plant and medical science, product development and innovation, brands, and international distribution.”
Aurora Cannabis Inc (OTCMKTS:ACBFF) is one of the most widely diversified players in the cannabis space due to its powerful strategic investments.
In addition to the Company’s rapid organic growth and strong execution on strategic M&A, which to date includes 15 companies – MedReleaf, CanvasRX, Peloton Pharmaceutical, Aurora Deutschland (formerly Pedanios), H2 Biopharma, Urban Cultivator, BC Northern Lights, Larssen Greenhouses, CanniMed Therapeutics, Anandia Labs, HotHouse Consulting, Agropro, Borela, and the pending acquisition of ICC Labs – Aurora is distinguished by its reputation as a partner of choice and employer of choice in the global cannabis sector.
The company has invested in and established strategic partnerships with a range of leading innovators, including: The Green Organic Dutchman Holdings Ltd. (TSX: TGOD), Radient Technologies Inc. (TSXV: RTI), Hempco Food and Fiber Inc. (TSXV: HEMP), Cann Group Ltd. (ASX: CAN), Micron Waste Technologies Inc. (CSE: MWM), Choom Holdings Inc. (CSE: CHOO), Namaste Technologies Inc. (TSXV: N), Evio Beauty Group (private), Wagner Dimas (private), CTT Pharmaceuticals (OTCC: CTTH), and Alcanna Inc. (TSX: CLIQ).
However, just drilling down into its core cannabis production operations, through Aurora Cannabis Enterprises Inc, trumpets itself as “one of the world’s largest and leading cannabis companies” and a licensed producer of medical cannabis pursuant to Health Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR).
The Company operates a 55,200 square foot, state-of-the-art production facility in Mountain View County, Alberta, known as Aurora Mountain, is currently constructing a second 800,000 square foot production facility, known as “Aurora Sky”, at the Edmonton International Airport, and has acquired, and is undertaking completion of a third 40,000 square foot production facility in Pointe-Claire, Quebec, on Montreal’s West Island.
Aurora Cannabis Inc (OTCMKTS:ACBFF) is pulling in trailing 12-month revenues of $42M, with revenues of $19.2 million for the quarter ended June 30, which is up 223% compared to the same period in 2017. In addition, the company is sitting on a mountain of assets, with its latest data showing over $167 million on the balance sheet against just $57M in debt.
As discussed above, ACBFF shares continue to benefit from the company’s growth along with its extremely rich and diversified base of strategic investments.
Mr. Booth added, “With coast-to-coast supply arrangements, and our strategic investment in Alcanna, we are very well positioned to capitalize on the significant adult consumer use opportunity in Canada. With reported Q4 revenues of $19.1 million, pro-forma Q4 revenues of over $33.1 million, and production capacity scaling up rapidly, we anticipate accelerated revenue growth during fiscal 2019. We have invested heavily in our organizational capabilities, including sales, marketing, and corporate talent and capacity, to ensure we will continue to drive strong and sustainable long-term growth.”
The stock has been very strong since securing technical support back in early August when shares briefly dipped down under the $5/share level for a few days. When that level was retaken by bulls, it was truly off to the races, and this quarterly report helps to explain why.
Mr. Booth concluded, “Today, Aurora ticks all the boxes for sustainable success and leadership in the cannabis industry. Aurora is capitalizing on a once in a lifetime opportunity, and establishing new industry standards in terms of execution, science, cultivation, international expansion and product development that position us exceptionally well to do so. We are very proud of our achievements over the past year, and we look forward to fiscal 2019 as we continue to execute.”
This Bioceutical Breakthrough May Hold the Key to the NFL’s Deadly CTE Crisis
Millionaires are being made by the moment in the medical marijuana industry. Venture capital firms, private equity firms, and even billionaires have gotten in on the action, sending key players to multi-bagger gains overnight.
One only has to remember InMed Pharmaceuticals’ (OTC: IMLFF / IN.V) launch from under a dime to $0.72 in 2017. Or GW Pharmaceuticals’ (NASDAQ: GWPH) sky-high climb when positive phase 3 results were released for Epidiolex to know that investors are churning out fast double, triple and quadruple digits gains.
If you missed those huge rallies, than you’re in luck because GridIron BioNutrients (OTC: GMVP) is just getting started.
With a total of 29 U.S. states legalizing the medical use of cannabis, and 8 with recreational-use laws in place, the market has been abuzz. A new report from the Brightfield Group projected the international market for cannabis to hit $31.4 billion by 2021, showing a compound annual growth rate of 60%.
And those figures could be vastly underestimated when taking into account the full scope of the market potential in development.
Wall Street is even getting in on the action, slating the launch of a new marijuana ETF for later this year or early 2018. Big tobacco and alcohol are late to the game, but showing signs of an entrance in the near term. You’re certain to have seen the recent headlines about Philip Morris’ $20 Million investment in Syqe… or Corona’s parent company, Constellation Brands taking a 9.9% share in $2 Billion medical marijuana company, Canopy Growth.
Their early hesitation could mean massive gains for your portfolio as acquisition hungry giants vie for their share of this multi-billion dollar behemoth.
Triggers on the very near horizon, such as coming legalization in the massive Californian and Canadian markets, are driving cannabis to be one of the most promising investments for 2018. And GridIron Bionutrients (OTC: GMVP) looks to be the best opportunity for this rapidly-growing market.
With an innovative product line, access to capital, and a contract in place with the NFL Alumni Association…All signs point to a winning addition to your portfolio.
Are your juices flowing yet? They should be. Here’s why…
This IPO May Hold the Key to the NFL’s Deadly CTE Crisis
The NFL is facing a revenue-crushing epidemic. CTE–the devastating brain disease stalking the NFL has sent dozens of companies scrambling for answers. Despite $1,500 helmets and neurosurgeons taking brain scans on the sidelines, medical experts say equipment can’t protect athletes enough to prevent lifelong brain damage.
But our newest feature company could save the game and generously reward early shareholders in the process. GridIron BioNutrients (GMVP) is taking this challenge head on with their groundbreaking sports drink, MVP Nano.
MVP Nano is organically produced and rich with probiotics and trace minerals. And then there’s one extra ingredient medical research has proved to be a neuroprotector—Cannabinoids.
You see, CTE or chronic traumatic encephalopathy is a specific type of permanent brain damage that is caused by multiple blows to the head over time. Doctors used to think it was rare. Then came the high-profile cases of athletes with the distinctive “tau” deposits of CTE getting in trouble or aging before their time.
The cannabinoid formula in MVP Nano is a powerful anti-oxidant, anti-inflammatory, and reduces the buildup of tau proteins. Drinking it before playing could protect players from the damage on sub-concussive hits to the head.
That’s a groundbreaking feat in its own rite… and one that could make GMVP a coveted acquisition target.
No other company is ready to market a sports-specific Hemp drink. This is how investors find beverage stocks that soar, like VitaminWater, which Coca-Cola acquired for $4.1 billion. That’s approximately 17 times what Vitamin Water’s annual sales were at the time! Musician 50 CENT was a shareholder in Vitamin Water and it’s rumored he made $100 million for his share.
The Amazing Power of Cannabinoids to Cushion the Brain
Scientists have known for years that cannabidiol, the active ingredient in MVP Nano, works powerfully to treat post-traumatic stress disorder, depression, anxiety, seizures and pain. But research just released in 2017 added startling extra dimension.
It turns out that there is now solid proof that cannabidiol is good for the brain. In the scientific jargon, it is a neuroprotector—and a stronger one than anyone expected.
The latest research shows that it could protect brains from the effects of ischemic strokes and head traumas and reduces the buildup of tau deposits.
With this proof of in hand, GridIron’s MVP Nano is game-ready, formulated, bottled and ready to save the game. But will the image-conscious National Football League approve of a drink with cannabidiol in it?
The National Football League Alumni Association already has!
NFLA represents retired players and markets products through its Pro Football Legends division. It just signed a three-year memorandum of understanding to work with GridIron
As you can see, GridIron isn’t wasting any time breaking into the mainstream sports beverage industry… press was just released introducing a brand new Alkaline Hemp Water to their product line.
“The formulation of Gridiron Hemp H2O Probiotics™ is a significant development for the Company,” said Darren Long, CEO of Gridiron. “We believe this exceptional product will allow Gridiron to strategically enter the ever-growing Hemp water marketplace at a competitive price point. Gridiron Hemp H2O Probiotics™ is a unique Alkaline water with a pH of 10 infused with Probiotics, Electrolytes and Certified Nano Hemp.”
NFL Can’t Dodge The Need for Help
The average NFL pro sustains 1,500 blows to the head every season. The worst damage usually doesn’t show up until years later as depression, violent outbursts, aggression, speech disorders, trembling, seizures, difficulty walking, inability to focus, disordered thoughts, and memory loss so severe it looks like advanced Alzheimer’s.
CTE has become a publicity nightmare for the NFL. Former New England Patriot Aaron Hernandez, who committed suicide at age 27, had history of violence including murder… and the worst case of CTE ever seen in a player so young. Four-time Super Bowl champ and Hall of Famer Mike Webster suffered dementia at age 50. His brain showed tau deposits equivalent to being in 25,000 car crashes.
The CTE-football link in today’s game is irrefutable. Researchers at Boston University have found evidence of CTE in 110 of the 111 brains of former NFL players it has autopsied.
Dr. Bennett Omalu, the neurologist who first pinpointed the problem in 2005, puts it starkly …
“If you get to the professional level, I believe there is a 100% chance you have brain damage.”
The NFL has every reason to adopt a protective beverage like MVP Nano immediately.
- It owes a $1 billion settlement to ex-NFL players suffering CTE, and that will rise unless the damage is stopped.
- Promising young athletes like Chris Borland are dropping out of the game early to avoid ending up hopelessly brain damaged.
- And worse for the future, 40% of parents won’t allow their children to learn how to play football in youth leagues and school sports anymore.
Even LeBron James—who was a star wide receiver in high school and recruited by Notre Dame—won’t let his sons play football.
So why wouldn’t the NFL put MVP Nano’s sleek black bottle right out front—Nano MVP, sitting proudly next to that ubiquitous green cooler. It’s the only cannbidiol-enhanced drink formulated by athletes who know nutrition!
GridIron Is Run By Athletes for Athletes
GridIron’s CEO Dan Long is a former pro football player himself. That could be the reason that GridIron is the first and only cannabidiol-enhanced product that we know of to reach a deal with the NFLA.
But Long’s not just a jock. He understands what’s in the bottle and what the right nutrients and bioceuticals can achieve. He has a bachelor’s degree in nutrition from California State University, Long Beach.
GridIron’s Treasurer and director Brian Martinho got his B.S. from San Diego State in Exercise and Nutritional Science. And Timothy Orr, GridIron’s president, has a JD from Gonzaga Law… but before that, he earned his B.A. in Biology from Whitworth University.
Acquisition Potential Is Sky High
If you know the beverage industry, you have probably figured out the real reason to own GridIron BioNutrients (OTC: GMVP)—buyout potential.
The giants of the industry rarely develop new products. They wait for young companies like GridIron to develop and test good ideas, then they pounce, often coughing up 4 to 17 X annual sales. Just the way PepsiCo bought Gatorade and Coke took over PowerAde.
GridIron BioNutrients is still in early development, itself having been only recently acquired by parent company MyCloudz. That makes it an ideal time to stake out a speculative position for high rewards. Beverage stocks that find a new market can turn into real moonshot for investors—with share value rising as much as 20X like we saw with Samuel Adams or for an astounding 90X catapult, as we saw with Starbucks.
GMVP is staking out an entirely new niche, and you don’t want to miss out on this one. Take a look at their corporate presentation:
Digipath Inc. (OTCMKTS: DIGP) Announce Significant Milestones On Development Of GroSciences Hemp-Test Kit
Post Views: 327 Digipath Inc. (OTCMKTS:DIGP) has announced that its GroSciences subsidiary has made substantial progress in the development of...
Harvest Health & Recreation Inc (OTCMKTS:HRVSF) Launches Expands Its Footprint In Florida With New Medical Marijuana dispensary in Gainesville
Post Views: 359 Harvest Health & Recreation Inc (OTCMKTS:HRVSF) recently announced that it launched a new outlet in Gainesville, making...
Harvest Health & Recreation Inc (OTCMKTS:HRVSF) Gets Greenlight To Expand Its Foreign Private ISSUER Threshold
Post Views: 328 Harvest Health & Recreation Inc (OTCMKTS:HRVSF) revealed earlier this month that its Board of Directors has approved...
Generex Biotechnology Corporation (OTCMKTS:GNBT) Adds MediSource Partners And Pantheon Medical To Its NuGenerex Family Of Subsidiaries
Post Views: 286 Generex biotechnology Corporation (OTCMKTS:GNBT) has welcomed MediSource Partners to its family of subsidiaries and introduced Pantheon Medical...
CBD Unlimited Inc. (OTCMKTS:EDXC) Enhances Its Convenience Store Program Targeting 300 Stores
Post Views: 274 CBD Unlimited Inc. (OTCMKTS:EDXC), formerly Endexx Corporation, has announced an enhanced convenient store launch program. The provider...
Cronos Group Inc. (NASDAQ:CRON) Spends $300 Million On CBD Skincare Businesses
Post Views: 261 Cronos Group Inc. (NASDAQ:CRON) has not had the best of runs in recent months, after starting the...
Elev8 Brands, Inc. (OTCMKTS:VATE) A Potential Break Out Play On Sales Growth Boost
Post Views: 277 Elev8 Brands, Inc. (OTCMKTS:VATE) stock is a potential break out play as a flurry of positive developments...
Medical Marijuana Inc. (OTCMKTS:MJNA) Eyes Fresh Gains On Improving Fundamentals
Post Views: 173 Medical Marijuana Inc. (OTCMKTS:MJNA) bounce back from all-time lows continues to gather pace on improving fundamentals. Investor’s...
Sugarmade Inc. (OTCMKTS:SGMD) Turns To Hemp Production To Reinvigorate Growth Prospects
Post Views: 180 Sugarmade Inc. (OTCMKTS:SGMD) has made a strategic investment in Hempistry as it tries to reinvigorate its growth...
Auxly Cannabis Group Inc (OTCMKTS:CBWTF) Acquires 46% Stake In Curative Cannabis And Agrees to Fund Cannabis Cultivation Facility To Produce Ultra Premium Cannabis
Post Views: 180 Auxly Cannabis Group Inc (OTCMKTS:CBWTF) has entered a deal to take over a 46% stake in Curative...
Health3 years ago
Medical Marijuana Inc (OTCMKTS:MJNA) Enters Mexico With Hemp Oil
PROFILES1 year ago
Could PLSI Be Poised to Dominate the International Cannabis Market?
Uncategorized2 years ago
Study Unveils Hemp Could Treat These 10 Chronic Conditions
PROFILES1 year ago
For the Next Wave of Marijuana Profits, Look to Real Estate
PROFILES12 months ago
California cannabis stocks take off after new July 1 regulations
Business12 months ago
Aurora Cannabis Inc (NYSE:ACB) Sets Out for Global Domination with ICC Move
Business2 years ago
Will McKesson Make Maricann Canada’s Next Unicorn Stock?
Business1 year ago
New Age Beverages Corp (NASDAQ:NBEV) Gears Up for a Big Week